My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 127

    1.

    Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin.

    Matheu V, Perez E, Hernández M, Díaz E, Darias R, González A, García JC, Sánchez I, Feliciano L, Caballero A, de la Torre F.

    Clin Mol Allergy. 2005 Dec 23;3:16.PMID: 16375762 [PubMed]Related articlesFree article

    2.

    Severe insulin allergy after percutaneous transluminal coronary angioplasty.

    Wang C, Ding ZY, Shu SQ, Liu Y, Chen YC, Ran XW, An ZM, Tian HM, Tong NW, Li XJ, Yu YR.

    Clin Ther. 2009 Mar;31(3):569-74.PMID: 19393846 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion.

    Moyes V, Driver R, Croom A, Mirakian R, Chowdhury TA.

    Diabet Med. 2006 Feb;23(2):204-6.PMID: 16433720 [PubMed - indexed for MEDLINE]Related articles

    5.

    A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.

    Adachi A, Fukunaga A, Horikawa T.

    Int J Dermatol. 2004 Aug;43(8):597-9.PMID: 15304187 [PubMed - indexed for MEDLINE]Related articles

    7.

    Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

    Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

    Clin Ther. 2005;27 Suppl B:S75-88. Review.PMID: 16519039 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cutaneous insulin allergy responsive to oral desensitisation and aspirin.

    Holdaway IM, Wilson JD.

    Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1565-6.PMID: 6439319 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report.

    Pföhler C, Müller CS, Hasselmann DO, Tilgen W.

    J Med Case Reports. 2008 Aug 26;2:283.PMID: 18727824 [PubMed]Related articlesFree article

    10.

    Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

    Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

    Clin Ther. 2005;27 Suppl B:S57-74. Review.PMID: 16519038 [PubMed - indexed for MEDLINE]Related articles

    11.

    Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus.

    Chlup R, Zapletalová J, Seckar P, Malá E, Doubravová B, Táncosová S, Chlupová L, Pukowietz L, Zatloukal P.

    Diabetes Technol Ther. 2007 Jun;9(3):223-31.PMID: 17561792 [PubMed - indexed for MEDLINE]Related articles

    12.

    Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes.

    Marusic S, Vlahovic-Palcevski V, Ljubanovic D.

    Int J Clin Pharmacol Ther. 2009 Oct;47(10):603-5.PMID: 19825323 [PubMed - indexed for MEDLINE]Related articles

    13.

    Primary systemic allergy to human insulin: recurrence of generalized urticaria after successful desensitization.

    Chng HH, Leong KP, Loh KC.

    Allergy. 1995 Dec;50(12):984-7.PMID: 8834829 [PubMed - indexed for MEDLINE]Related articles

    14.

    Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.

    Kawasaki F, Kamei S, Tatsumi F, Hamamoto S, Shimoda M, Tawaramoto K, Shigeto M, Kanda Y, Hashiramoto M, Matsuki M, Kaku K.

    Intern Med. 2009;48(17):1545-9. Epub 2009 Sep 1.PMID: 19721301 [PubMed - in process]Related articlesFree article

    15.

    Cost-effectiveness of insulin analogues for diabetes mellitus.

    Cameron CG, Bennett HA.

    CMAJ. 2009 Feb 17;180(4):400-7.PMID: 19221353 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.

    Moses RG, Bartley P, Lunt H, O'Brien RC, Donnelly T, Gall MA, Vesterager A, Wollmer P, Roberts A.

    Diabet Med. 2009 Mar;26(3):260-7.PMID: 19317821 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Intracutaneous desensitization in a case of insulin allergy with anaphylactic shock (author's transl)]

    Bachmann W, Hasche H, Haslbeck M, Mehnert H.

    Dtsch Med Wochenschr. 1979 Jul 13;104(28):1014-6. German. PMID: 456275 [PubMed - indexed for MEDLINE]Related articles

    18.

    Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.

    Raja-Khan N, Warehime SS, Gabbay RA.

    Vasc Health Risk Manag. 2007;3(6):919-35. Review.PMID: 18200811 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

    Ligthelm RJ, Mouritzen U, Lynggaard H, Landin-Olsson M, Fox C, le Devehat C, Romero E, Liebl A.

    Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):511-9.PMID: 17115349 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk